SEC Form 4 · accession 0001179110-19-003120
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph J Manning
Officer — Senior Vice President
Period of report
Feb 28, 2019
Accepted (ET)
Mar 4, 2019 · 5:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par valueF1 | Feb 28, 2019 | A | 7,288 | $0.00 | A | 61,324 | D | |
| Common shares without par value | Feb 28, 2019 | F | 3,959 | $77.23 | D | 57,365 | D | |
| Common shares without par value | Mar 1, 2019 | S | 1,223 | $78.00 | D | 56,142 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Settlement of performance-based restricted stock units in shares in a transaction exempt from Section 16(b) under Rule 16b-3.